About Sciences Peptides

Sciences Peptides is a personal research blog. It exists because the writer spent years buying, testing, and documenting research peptides and found that the single most useful body of knowledge in the field — how to read a certificate, how to price-check a lot, how to evaluate a seller's public footprint — is scattered across forums, buried in vendor marketing, and absent from the places buyers actually look. This site is that knowledge, written down properly.

The site is organized as a pillar-cluster reference. Four long-form pillars anchor the field: peptide science (synthesis, purity, documentation), where to buy peptides (the market, its tiers, and how to search it), top peptide companies (company research and the seven-question checklist), and the Peptide Sciences hub (the field's most-searched seller, as a case study). Every shorter article belongs to exactly one cluster and links back to its pillar.

It is not a store, an affiliate site, or an advisory service. We sell nothing, take no placements or commissions, and maintain no financial relationships with any vendor profiled or listed in the directory. Company pages summarize public information and are not endorsements; the editorial policy documents the sourcing and update standards, and the disclaimer bounds the scope of everything published here.

It is also not a medical resource. All content describes laboratory-research contexts only. Nothing on this site advises human or veterinary use of any compound, and no page describes dosing, cycles, or outcomes for people. Readers with health questions should consult qualified clinicians, not research blogs.

The site is written by a single researcher with a laboratory background, edited under the site's own evidence tiers, and dated. Sources are listed per article in the reference boxes; community sentiment is used only as sentiment, never as proof — the weighting rules are part of the editorial policy above.

Corrections and documentation-based updates are welcome via the contact page. If you can point to a dated COA, a registry filing, or an archived snapshot that contradicts something published here, it will be reviewed and, where it holds, corrected with a note. That offer is symmetric: it applies to our treatment of every company in the company research cluster.